-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
SJvopsO/9XrnSnD92n/p5GWnP+6EkRGV05tvpXLDqaMXIMC+8dh/Gw5B3A0JAGHB
bIcydCzP+i/lGl+7vRAuKg==
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 10-Q (Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2003 or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ________to _________
Commission File Number 0-21229
Stericycle, Inc.
28161 North Keith Drive
(847) 367-5910
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file reports), and (2) has been subject to such filing
requirements for the past 90 days. YES [X] NO [ ],
Indicate by check mark whether the Registrant is an accelerated filer (as
defined in Exchange Act Rule 12b-2). YES [X] NO [ ],
As of May 1, 2003 there were 40,749,291 shares of the Registrant's
Common Stock outstanding.
Stericycle, Inc.
PART I -- FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS
STERICYCLE, INC. AND SUBSIDIARIES
The accompanying notes are an integral part of these financial statements
STERICYCLE, INC. AND SUBSIDIARIES
The accompanying notes are an integral part of these financial statements
STERICYCLE, INC. AND SUBSIDIARIES
The accompanying notes are an integral part of these financial statements
STERICYCLE, INC. AND SUBSIDIARIES
Unless the context requires otherwise, "we", "us" or "our" refers to
Stericycle, Inc. and its subsidiaries on a consolidated basis. NOTE 1--BASIS OF PRESENTATION The accompanying condensed consolidated financial
statements have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission. Certain information and footnote disclosures
normally included in annual consolidated financial statements prepared in
accordance with generally accepted accounting principles have been condensed or
omitted pursuant to such rules and regulations; but the Company believes the
disclosures in the accompanying condensed consolidated financial statements are
adequate to make the information presented not misleading. In our opinion, all
adjustments necessary for a fair presentation for the periods presented have
been reflected and are of a normal recurring nature. These condensed
consolidated financial statements should be read in conjunction with the
Consolidated Financial Statements and notes thereto for the year ended December
31, 2002, as filed with our Annual Report on Form 10-K for the year ended
December 31, 2002. The results of operations for the three-month period ended
March 31, 2003 are not necessarily indicative of the results that may be
achieved for the entire year ending December 31, 2003. NOTE 2-ACQUISITIONS During the quarter ended March 31, 2003 we completed two
acquisitions. In January, we completed our acquisition, by a reverse subsidiary
merger, of all the common and preferred stock of Scherer Healthcare, Inc., which
operated two business lines: (i) consumer healthcare products and (ii) waste
management services, the latter of which focuses primarily on containment,
control, collection and processing of sharp-edged medical waste. Scherer's
reusable sharps programs are marketed through its Bio Systems subsidiaries in 10
northeastern and mid-Atlantic states plus the District of Columbia. In addition
in January, we completed our acquisition of selected assets from Kuglen
Services, Ltd., LLP, which operated in Texas. The aggregate purchase price of
the two acquisitions was $31.3 million in cash, net of cash acquired. NOTE 3--STOCK OPTIONS During the quarter ended March 31, 2003, options to
purchase 842,359 shares of common stock were granted to employees. These options
vest ratably over a five-year period and have exercise prices of $33.05-$35.79
per share. Pro forma information regarding net income and net income per
share is required by FAS 123 as if we had accounted for our employee stock
options granted subsequent to December 31, 1994 under the fair value method of
that statement. Options granted were valued using the Black-Scholes option-
pricing model. Option value models require the input of highly subjective
assumptions. Because our employee stock options have characteristics
significantly different from those of traded options, and because changes in the
subjective input assumptions can materially affect the fair value estimate, in
management's opinion, the existing method does not necessarily provide a
reliable single measure of the fair value of its employee stock options. For purposes of pro forma disclosures, the estimated fair
value of the options is amortized to expense over the option-vesting period.
Our pro forma information follows (in thousands, except for per share
information): NOTE 4-COMMON STOCK. During the quarter ended March 31, 2003, options to
purchase 219,570 shares of common stock were exercised at prices ranging from
$1.00-$27.37 per share. In addition warrants with rights to purchase 7,666
shares of common stock were exercised at a price of $8.75 per share. We also
issued 2,011 shares of common stock in connection with an acquisition agreement
made in a previous quarter and cancelled 2,918 shares of common stock previously
issued in connection with an acquisition in a previous quarter. NOTE 5--DERIVATIVE INSTRUMENTS We had interest rate swap agreements that
effectively converted a portion of our floating-rate debt to a fixed-rate basis,
thus reducing the impact of interest rate changes on future interest expense.
These agreements expired during the quarter ended March 31, 2003. Activity related to the accumulated loss on derivative
instruments is as follows: NOTE 6-NET INCOME PER COMMON SHARE The following table sets forth the computation of basic and
diluted net income per share:
STERICYCLE, INC. AND SUBSIDIARIES NOTE 7-COMPREHENSIVE INCOME The
components of total comprehensive income are net income, change in cumulative
currency translation adjustments and the change in cumulative unrealized losses
on derivative instruments recorded in accordance with FAS 133. The
following table details the total comprehensive income for the current and prior
year periods. NOTE 8-GOODWILL AND OTHER INTANGIBLES We have two geographical reporting segments, United States and Foreign
Countries, both of which have goodwill. The changes in the carrying amount of
goodwill for the three months ended March 31, 2003, was as follows (in
thousands): At March 31, 2003, we had $20.9 million in the goodwill
balance related to the Scherer acquisition that we recently completed in which
the assignment of intangibles and goodwill had not yet been determined. According to FAS 142, other intangible assets will continue
to be amortized over their useful lives. During the quarter ended March 31,
2003 we recorded at fair value the intangibles acquired in connection with our
acquisition during the quarter of certain of the assets of Kuglen Services Ltd,
LLP. We assigned $1.14 million to customer relationships with an amortization
period of 40 years, similar to that of our other customer relationship
intangibles. NOTE 9-DEBT In January 2003 we amended our senior secured credit
facility to increase our borrowing capacity by $51.0 million by reclassifying
borrowings under our revolving credit facility to Term A loans. At March 31,
2003 the credit facility consisted of a $105.0 million revolving credit
facility, a $107.6 million Term A loan facility and a $47.0 million Term B loan
facility. At March 31, 2003 we had $8.0 million outstanding under our
revolving credit facility. Under the credit agreement as amended in January 2003, we
extended the maturity of the revolving credit component and the Term A loan
component to September 2007 and extended the maturity of the Term B component to
September 2008. Both term loans are repayable in quarterly installments on the
last business day of March, June, September, and December beginning in 2003.
The required principal repayments under the Term A loan component are $5.0
million on each quarterly payment date through June 2007, with a final payment
of the outstanding principal balance upon maturity in September 2007. The
required principal payments under the Term B Loan component are $0.2 million on
each quarterly payment date through June 2008, with a final payment of the
outstanding balance upon maturity in September 2008. NOTE 10-LEGAL PROCEEDINGS We operate in a highly regulated industry and are exposed to regulatory
inquiries or investigations from time to time. Investigations can be initiated
for a variety of reasons. We have been involved in several legal and
administrative proceedings that have been settled or otherwise resolved on terms
acceptable to us, without having a material adverse effect on our business,
financial condition or results of operations. We are also a party to various
legal proceedings arising in the ordinary course of business. We believe that
the resolutions of these other matters will not have a material adverse affect
on our business, financial condition or results of operation. In September 2002, we entered into a consent decree implementing the
terms of settlement with the Arizona Attorney General's office of its antitrust
investigation relating to our December 1997 sale and purchase of medical waste
assets in Utah and Arizona with BFI and our subsequent failure to provide
treatment services to certain third-party haulers of medical waste at our
treatment facilities in Arizona and Utah. Under the consent decree, we are
required to pay a total of $0.3 million in civil penalties and attorneys' fees
in quarterly installments over a three-year period, with an initial payment of
$0.1 million. We are also required to provide up to 50,000 pounds per month of
incineration treatment services to third-party haulers at our Chandler, Arizona
treatment facility for a five-year period at commercially competitive prices. In
addition, we are required, for a two-year period to rebate 25% of the amounts
billed and collected from the two third-party haulers whose complaints prompted
the initial investigation. In January 2003, we reached a definitive settlement of the antitrust
investigation by the Utah Attorney General's office relating to the same issues.
Under the terms of the consent decree incorporating this settlement, we agreed
to pay a total of $0.6 million to the Attorney General's office over a three-
year period. We also agreed to make certain operational changes in Utah to
enhance competition, including providing incineration treatment services to
third party haulers at our Salt Lake City treatment facility. In January 2003, we were sued in federal court in Arizona by a private
plaintiff alleging anticompetitive conduct in Arizona, Colorado and Utah from
November 1997 to the present and seeking certification of the lawsuit as a class
action on behalf of all customers of Stericycle and BFI in the three-state area
during the period in question. In February and March 2003, three similar suits
were filed in federal court in Arizona, Colorado and Utah, and in April 2003, a
fifth similar suit was filed in federal court in New Mexico. In addition, in
February 2003, a sixth suit, alleging substantially the same anticompetitive
conduct but not seeking class action certification, was filed in federal court
in Utah. We have moved to transfer and consolidate all six lawsuits in federal
court in Utah. We believe that none of the lawsuits has any merit. We and certain of our officers and directors are parties to a lawsuit filed
in July 2002 by a shareholder of our majority-owned subsidiary, 3CI Complete
Compliance Corporation ("3CI"). The lawsuit, which was filed on behalf
of the minority shareholders of 3CI and derivatively on behalf of 3CI itself,
alleges, among other things, that we and 3CI's directors (who, in all but one
case, are also officers or directors of ours) unjustly enriched Stericycle at
the expense of 3CI and its other shareholders. The plaintiff seeks, among other
relief, damages and an order requiring the buyout of 3CI's minority
shareholders. The lawsuit is still at a very early stage. We believe that the
plaintiff's claims are without merit. NOTE 11--CONDENSED CONSOLIDATING FINANCIAL INFORMATION Payments under our senior subordinated notes (the
Notes) are unconditionally guaranteed, jointly and severally, by certain of our
wholly-owned domestic subsidiaries (collectively, "the guarantors"). Financial
information concerning the guarantors as of March 31, 2003 and December 31, 2002
and for the three month periods ended March 31, 2003 and 2002 is presented below
for purposes of complying with the reporting requirements of the guarantor
subsidiaries. The financial information concerning the guarantors is being
presented through condensed consolidating financial statements since we have
more than minimal independent operations and the guarantees are full and
unconditional and are joint and several. Financial statements for the guarantors
have not been presented because management does not believe that such financial
statements are material to investors.
CONDENSED CONSOLIDATING BALANCE SHEET
CONDENSED CONSOLIDATING BALANCE SHEET
CONDENSED CONSOLIDATING STATEMENT OF INCOME
CONDENSED CONSOLIDATING STATEMENT OF INCOME
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS We were incorporated in March 1989. We provide
compliance services including regulated medical waste collection, transportation
and treatment services to our customers and related training and education
programs and consulting services. We also sell ancillary supplies and transport
pharmaceuticals, photographic chemicals, lead foil and amalgam for recycling in
selected geographic service areas. We are also expanding into international
markets through joint ventures and/or by licensing our proprietary technology
and selling associated equipment. THREE MONTHS ENDED MARCH 31, 2003 COMPARED TO THREE MONTHS ENDED MARCH 31,
2002
(Exact name of registrant as specified in its charter)
Lake Forest, Illinois 60045
(Address of principal executive offices including zip code)
(Registrant's telephone number, including area code)
Table of Contents
PART I. Financial Information
Page No.
Item 1. Financial Statements
Condensed Consolidated Balance Sheets as of
March 31, 2003 (Unaudited) and December 31, 2002
Condensed Consolidated Statements of Income
for the three months ended March 31, 2003 and 2002 (Unaudited)
Condensed Consolidated Statements of Cash Flows
for the three months ended March 31, 2003 and 2002 (Unaudited)
Notes to Condensed Consolidated Financial Statements (Unaudited)
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations
Item 3. Qualitative and Quantitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II. Other Information
Item 1. Legal Proceedings
Item 2-5. None
Item 6. Exhibits and Reports on Form 8-K
Signatures
Certifications
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
March 31, December 31
2003 2002
----------- -----------
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents.................................. $ 9,188 8,375
Short-term investments..................................... 1,141 512
Accounts receivable, less allowance for doubtful
accounts of $4,366 in 2003 and $3,779 in 2002............ 68,540 62,013
Parts and supplies......................................... 5,279 4,494
Prepaid expenses........................................... 5,109 7,170
Notes receivable........................................... 823 823
Deferred tax asset......................................... 6,579 6,720
Other...................................................... 3,442 4,249
----------- -----------
Total current assets.............................. 100,101 94,356
Property, plant and equipment, net......................... 93,552 88,501
Other assets:
Goodwill, less accumulated amortization of $32,374
in 2003 and 2002......................................... 469,389 447,272
Intangible assets, less accumulated amortization of -- --
$6,800 in 2003 and $3,609 in 2002........................ 21,042 20,110
Notes receivable........................................... 7,717 7,717
Other...................................................... 8,385 9,139
----------- -----------
Total other assets....................................... 506,533 484,238
----------- -----------
Total assets...................................... $ 700,186 $ 667,095
=========== ===========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Current portion of long term debt.......................... $ 25,156 $ 3,933
Accounts payable........................................... 12,637 14,330
Accrued liabilities........................................ 36,111 31,810
Deferred revenue........................................... 4,401 3,681
----------- -----------
Total current liabilities......................... 78,305 53,754
----------- -----------
Long-term debt, net of current portion..................... 210,473 224,124
Deferred income taxes...................................... 34,143 30,729
Other liabilities.......................................... 4,446 3,710
Redeemable preferred stock:
Series A convertible preferred stock (par value $.01 share,
75,000 shares authorized, 29,326 outstanding in 2003
and 2002, liquidation preference of $31,919 in 2003
and 2002).............................................. 28,049 28,049
Common shareholders' equity:
Common stock (par value $.01 per share, 80,000,000
shares authorized, 40,656,919 issued and outstanding in
in 2003, 40,437,023 issued and outstanding in 2002)...... 407 404
Additional paid-in capital................................. 280,680 277,531
Treasury stock............................................. (1,435) (1,435)
Accumulated other comprehensive loss....................... (21) (229)
Retained earnings.......................................... 65,139 50,458
----------- -----------
Total shareholders' equity................................. 344,770 326,729
----------- -----------
Total liabilities and shareholders' equity............... $ 700,186 $ 667,095
=========== ===========
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(unaudited)
Three Months Ended
March 31,
------------------------
2003 2002
----------- ------------
Revenues........................... $ 112,311 $ 97,064
Costs and expenses:
Cost of revenues................. 61,714 55,401
Selling, general and
administrative expenses........ 15,884 13,906
Depreciaton and amortization..... 4,264 3,563
Acquisition related costs........ 91 153
----------- -----------
Total costs and expenses...... 81,953 73,023
----------- -----------
Income from operations............. 30,358 24,041
----------- -----------
Other income (expense):
Interest income.................. 189 163
Interest expense................. (3,927) (5,809)
Debt extinguishments............. (1,628) --
Other expense.................... (645) (671)
----------- -----------
Total other income (expense).. (6,011) (6,317)
----------- -----------
Income before income taxes......... 24,347 17,724
Income tax expense................. 9,666 7,093
----------- -----------
Net income......................... $ 14,681 $ 10,631
=========== ===========
Earnings per share - Basic......... $ 0.36 $ 0.27
=========== ===========
Earnings per share - Diluted....... $ 0.32 $ 0.24
=========== ===========
Weighted average number of
common shares outstanding--Basic. 40,521,598 37,222,362
=========== ===========
Weighted average number of common
shares outstanding--Diluted...... 45,843,228 44,771,952
=========== ===========
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(unaudited)
For the Three
Months Ended March 31,
----------------------
2003 2002
---------- ----------
OPERATING ACTIVITIES:
Net income..................................................... $ 14,681 $ 10,631
Adjustments to reconcile net income to net cash
provided by operating activities:
Ineffective portion of cash flow hedges.................... -- (381)
Stock compensation expense................................. 76 --
Write-off deferred financing fees.......................... 247 --
Deferred tax expense....................................... 3,555 (728)
Tax benefit of disqualifying dispositions of stock options. 1,343 1,168
Loss on sale of fixed assets............................... 72 36
Depreciation............................................... 3,943 3,055
Amortization............................................... 321 508
Changes in operating assets and liabilities, net of
effect of acquisitions:
Accounts receivable........................................ (2,200) 4,279
Parts and supplies......................................... (279) 1,653
Prepaid expenses and other assets.......................... 5,626 (2,184)
Accounts payable........................................... (2,643) (3,035)
Accrued liabilities........................................ 3,368 8,106
Deferred revenue........................................... 165 (2,037)
---------- ----------
Net cash provided by operating activities...................... 28,275 21,071
---------- ----------
INVESTING ACTIVITIES:
Payments for acquisitions and international
investments, net of cash acquired.......................... (31,301) (3,975)
Short-term investments....................................... (629) (243)
Proceeds from sale of equipment.............................. 132 31
Capital expenditures......................................... (3,788) (3,867)
---------- ----------
Net cash used in investing activities.......................... (35,586) (8,054)
---------- ----------
FINANCING ACTIVITIES:
Net proceeds from issuance of note payable................... 1,132 1,181
Net proceeds from (repayments of) senior credit facility..... 15,814 (17,687)
Repurchase of senior subordinated debt....................... (9,129) --
Repayment of long term debt.................................. (752) --
Payments of deferred financing costs......................... (395) --
Principal payments on capital lease obligations.............. (252) (76)
Proceeds from issuances of common stock...................... 1,733 2,028
---------- ----------
Net cash provided by (used in) financing activities............ 8,151 (14,554)
Effect of exchange rate changes on cash........................ (27) 70
---------- ----------
Net increase (decrease) in cash and cash equivalents........... 813 (1,467)
Cash and cash equivalents at beginning of period............... 8,375 12,737
---------- ----------
Cash and cash equivalents at end of period..................... $ 9,188 $ 11,270
========== ==========
Non-cash activities:
Net issuances of common stock for certain acquisitions $ 70 $ 1,900
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2003
Quarter Ended March 31,
-----------------------
2003 2002
---------- ---------
As reported net income.................. $ 14,681 $ 10,631
Pro forma impact of stock options,
net of tax............................ 2,061 1,491
---------- ---------
Pro forma net income.................... $ 12,620 $ 9,140
========== =========
Pro forma net income per share-basic.... $ 0.31 $ 0.23
========== =========
Pro forma net income per share-diluted.. $ 0.28 $ 0.21
========== =========
Balance at December 31, 2002 $ (232)
Change in other comprehensive income associated
with year-to-date period hedge transactions 232
---------
Balance at March 31, 2003 $ --
=========
STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(UNAUDITED)
Three Months Ended
March 31,
------------------------
2003 2002
----------- -----------
Numerator:
Net Income................................ $ 14,681 $ 10,631
Preferred stock dividends................. 0 (404)
----------- -----------
Numerator for basic earnings
per share.............................. $ 14,681 $ 10,227
Effective of dilutive securities:
Preferred stock dividends............... 0 404
----------- -----------
Numerator for diluted earnings
per share-income available to
common shareholders after
assumed conversions...................... $ 14,681 $ 10,631
=========== ===========
Denominator:
Denominator for basic earnings per share
Weighted average shares.................. 40,521,598 37,222,362
----------- -----------
Effective of dilutive securities:
Employee stock options................... 1,558,686 1,832,056
Warrants................................. 115,276 123,970
Convertible preferred stock.............. 3,647,668 5,593,564
----------- -----------
Dilutive potential shares.................. 5,321,630 7,549,590
----------- -----------
Denominator for diluted earnings
per share-adjusted weighted
average shares and assumed
conversions................................ 45,843,228 44,771,952
=========== ===========
Earnings per share - Basic................... $ 0.36 $ 0.27
=========== ===========
Earnings per share - Diluted................. $ 0.32 $ 0.24
=========== ===========
Changes in Balance Sheet
------------------------- Total
Net Currency Derivative Comprehensive
Income Translation Instruments Income
--------------------------------------------------
Three months ended March 31, 2002 $ 10,631 $ 0 $ 1,462 $ 12,093
Three months ended March 31, 2003 14,681 (24) 232 14,889
United Foreign
States Countries Total
---------- --------- ----------
Balance as of January 1, 2003 $ 441,087 $ 6,185 $ 447,272
Goodwill acquired during year 22,117 0 22,117
---------- --------- ----------
Balance as of March 31, 2003 $ 463,204 $ 6,185 $ 469,389
========== ========= ==========
MARCH 31, 2003
UNAUDITED
COMBINED
STERICYCLE NON-
STERICYCLE, GUARANTOR AND GUARANTOR GUARANTOR
INC. SUBSIDIARIES SUBSIDIARIES SUBSIDIARIES ELIMINATIONS CONSOLIDATED
---------- ----------- ------------ ----------- ----------- ------------
ASSETS
Current assets:
Cash and cash equivalents.............. $ 5,624 $ 1,126 $ 6,750 $ 2,438 $ -- $ 9,188
Other current assets................... 82,011 23,374 105,385 9,506 (23,978) 90,913
---------- ----------- ------------ ----------- ----------- ------------
Total current assets...................... 87,635 24,500 112,135 11,944 (23,978) 100,101
Property, plant and equipment,
net.................................... 78,383 5,167 83,550 10,002 -- 93,552
Goodwill, net............................. 433,146 24,587 457,733 11,656 -- 469,389
Investment in subsidiaries................ 66,005 (334) 65,671 -- (65,671) --
Other assets.............................. 38,835 3,944 42,779 1,016 (6,651) 37,144
---------- ----------- ------------ ----------- ----------- ------------
Total assets.............................. $ 704,004 $ 57,864 $ 761,868 $ 34,618 $ (96,300) $ 700,186
========== =========== ============ =========== =========== ============
LIABILITIES AND SHAREHOLDERS'
EQUITY
Current liabilities:
Current portion of
long-term debt....................... $ 24,424 $ 268 $ 24,692 $ 464 $ $ 25,156
Other current liabilities.............. 64,090 2,776 66,866 10,261 (23,978) 53,149
---------- ----------- ------------ ----------- ----------- ------------
Total current liabilities................. 88,514 3,044 91,558 10,725 (23,978) 78,305
Long-term debt, net of current
portion................................ 206,709 445 207,154 9,970 (6,651) 210,473
Other liabilities......................... 35,962 -- 35,962 2,627 -- 38,589
Convertible preferred stock............... 28,049 -- 28,049 -- -- 28,049
Common shareholders' equity............... 344,770 54,375 399,145 11,296 (65,671) 344,770
---------- ----------- ------------ ----------- ----------- ------------
Total liabilities and
shareholders' equity................... $ 704,004 $ 57,864 $ 761,868 $ 34,618 $ (96,300) $ 700,186
========== =========== ============ =========== =========== ============
DECEMBER 31, 2002
AUDITED
COMBINED
STERICYCLE NON-
STERICYCLE, GUARANTOR AND GUARANTOR GUARANTOR
INC. SUBSIDIARIES SUBSIDIARIES SUBSIDIARIES ELIMINATIONS CONSOLIDATED
---------- ----------- ------------ ----------- ----------- ------------
ASSETS
Current assets:
Cash and cash equivalents.............. $ 5,818 $ 733 $ 6,551 $ 1,824 $ -- $ 8,375
Other current assets................... 75,798 31,453 107,251 10,666 (31,936) 85,981
---------- ----------- ------------ ----------- ----------- ------------
Total current assets...................... 81,616 32,186 113,802 12,490 (31,936) 94,356
Property, plant and equipment,
net.................................... 72,638 6,026 78,664 9,837 -- 88,501
Goodwill, net............................. 399,646 35,972 435,618 11,654 -- 447,272
Investment in subsidiaries................ 98,772 767 99,539 -- (99,539) --
Other assets.............................. 30,768 12,216 42,984 887 (6,905) 36,966
---------- ----------- ------------ ----------- ----------- ------------
Total assets.............................. $ 683,440 $ 87,167 $ 770,607 $ 34,868 $ (138,380) $ 667,095
========== =========== ============ =========== =========== ============
LIABILITIES AND SHAREHOLDERS'
EQUITY
Current liabilities:
Current portion of
long-term debt....................... $ 3,881 $ -- $ 3,881 $ 52 $ -- $ 3,933
Other current liabilities.............. 70,958 908 71,866 9,891 (31,936) 49,821
---------- ----------- ------------ ----------- ----------- ------------
Total current liabilities................. 74,839 908 75,747 9,943 (31,936) 53,754
Long-term debt, net of current
portion................................ 221,545 -- 221,545 9,484 (6,905) 224,124
Other liabilities......................... 32,278 (387) 31,891 2,548 -- 34,439
Convertible preferred stock............... 28,049 -- 28,049 -- -- 28,049
Common shareholders' equity............... 326,729 86,646 413,375 12,893 (99,539) 326,729
---------- ----------- ------------ ----------- ----------- ------------
Total liabilities and
shareholders' equity................... $ 683,440 $ 87,167 $ 770,607 $ 34,868 $ (138,380) $ 667,095
========== =========== ============ =========== =========== ============
THREE MONTHS ENDED MARCH 31, 2003
UNAUDITED
COMBINED
STERICYCLE NON-
STERICYCLE, GUARANTOR AND GUARANTOR GUARANTOR
INC. SUBSIDIARIES SUBSIDIARIES SUBSIDIARIES ELIMINATIONS CONSOLIDATED
---------- ----------- ------------ ----------- ----------- ------------
Revenues.................................. $ 99,184 $ 5,289 $ 104,473 $ 8,601 $ (763) $ 112,311
Cost of revenues.......................... 56,104 3,724 59,828 6,078 (739) 65,167
Selling, general, and
administrative expense................. 13,881 1,059 14,940 1,755 -- 16,695
Acquisition related expenses.............. 91 -- 91 -- -- 91
---------- ----------- ------------ ----------- ----------- ------------
Total costs and expenses.................. 70,076 4,783 74,859 7,833 (739) 81,953
---------- ----------- ------------ ----------- ----------- ------------
Income from operations.................... 29,108 506 29,614 768 (24) 30,358
Equity in net income (loss) of
subsidiaries........................... 1,004 17 1,021 -- (1,021) --
Other (expense) income, net............... (5,854) 53 (5,801) (234) 24 (6,011)
---------- ----------- ------------ ----------- ----------- ------------
Income before income taxes................ 24,258 576 24,834 534 (1,021) 24,347
Income tax expense........................ 9,577 204 9,781 (115) -- 9,666
---------- ----------- ------------ ----------- ----------- ------------
Net income................................ $ 14,681 $ 372 $ 15,053 $ 649 $ (1,021) $ 14,681
========== =========== ============ =========== =========== ============
THREE MONTHS ENDED MARCH 31, 2002
UNAUDITED
COMBINED
STERICYCLE NON-
STERICYCLE, GUARANTOR AND GUARANTOR GUARANTOR
INC. SUBSIDIARIES SUBSIDIARIES SUBSIDIARIES ELIMINATIONS CONSOLIDATED
---------- ----------- ------------ ----------- ----------- ------------
Revenues.................................. $ 83,608 $ 4,864 $ 88,472 $ 9,484 $ (892) $ 97,064
Cost of revenues.......................... 49,511 3,071 52,582 6,508 (915) 58,175
Selling, general, and
administrative expense................. 12,931 224 13,155 1,573 (33) 14,695
Acquisition related expenses.............. 153 -- 153 -- -- 153
---------- ----------- ------------ ----------- ----------- ------------
Total costs and expenses.................. 62,595 3,295 65,890 8,081 (948) 73,023
---------- ----------- ------------ ----------- ----------- ------------
Income from operations.................... 21,013 1,569 22,582 1,403 56 24,041
Equity in net income (loss) of
subsidiaries........................... 2,176 359 2,535 -- (2,535) --
Other (expense) income, net............... (6,125) 71 (6,054) (263) -- (6,317)
---------- ----------- ------------ ----------- ----------- ------------
Income before income taxes................ 17,064 1,999 19,063 1,140 (2,479) 17,724
Income tax expense (benefit).............. 6,489 625 7,114 (21) -- 7,093
---------- ----------- ------------ ----------- ----------- ------------
Net income................................ $ 10,575 $ 1,374 $ 11,949 $ 1,161 $ (2,479) $ 10,631
========== =========== ============ =========== =========== ============
THREE MONTHS ENDED MARCH 31, 2003
UNAUDITED
COMBINED
STERICYCLE NON-
STERICYCLE, GUARANTOR AND GUARANTOR GUARANTOR
INC. SUBSIDIARIES SUBSIDIARIES SUBSIDIARIES ELIMINATIONS CONSOLIDATED
---------- ----------- ------------ ----------- ----------- ------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash provided by
operating activities................. $ 27,041 $ 622 $ 27,663 $ 612 $ -- $ 28,275
---------- ----------- ------------ ----------- ----------- ------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures................... (3,109) (183) (3,292) (496) -- (3,788)
Proceeds from sale of equipment........ 132 -- 132 -- 132
Payments for acquisitions and
international investments, net of
cash acquired........................ (2,601) (28,700) (31,301) -- -- (31,301)
Short-term investments................ -- -- -- (629) -- (629)
---------- ----------- ------------ ----------- ----------- ------------
Net cash used in investing activities (5,578) (28,883) (34,461) (496) -- (35,586)
---------- ----------- ------------ ----------- ----------- ------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from senior credit facilit 15,814 -- 15,814 -- -- 15,814
Principal payments on capital lease
obligations.......................... (274) (46) (320) 68 -- (252)
Repayment of long term debt............ (706) -- (706) (46) -- (752)
Repurchase of senior subordinated debt. (9,129) -- (9,129) -- -- (9,129)
Payments of deferred financing costs... (395) -- (395) -- -- (395)
Net proceeds/(repayments) from issuance
of notes payable..................... -- -- -- 1,132 -- 1,132
Proceeds from issuance of common --
stock................................ 1,733 -- 1,733 -- -- 1,733
Intercompany financing of acquisitions. (28,700) 28,700 -- -- -- --
---------- ----------- ------------ ----------- ----------- ------------
Net cash provided by financing activities. (21,657) 28,654 6,997 1,154 -- 8,151
---------- ----------- ------------ ----------- ----------- ------------
Effect of exchange rate changes on cash... -- -- (27) (27)
---------- ----------- ------------ ----------- ----------- ------------
Net increase/(decrease) in cash and
cash equivalents....................... $ (194) $ 393 $ 199 $ 1,243 $ -- 813
========== =========== ============ =========== ===========
Cash and cash equivalents at beginning
of period.............................. 8,375
------------
Cash and cash equivalents at end of
period................................. $ 9,188
============
THREE MONTHS ENDED MARCH 31, 2002
UNAUDITED
COMBINED
STERICYCLE NON-
STERICYCLE, GUARANTOR AND GUARANTOR GUARANTOR
INC. SUBSIDIARIES SUBSIDIARIES SUBSIDIARIES ELIMINATIONS CONSOLIDATED
---------- ----------- ------------ ----------- ----------- ------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash provided by
operating activities................. $ 21,978 $ (400) $ 21,578 $ (507) $ -- $ 21,071
---------- ----------- ------------ ----------- ----------- ------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures................... (3,565) (78) (3,643) (224) -- (3,867)
Proceeds from sale of equipment........ 31 -- 31 -- 31
Payments for acquisitions and
international investments, net of
cash acquired........................ (1,004) (2,159) (3,163) (812) -- (3,975)
Short-term investments................. (243) -- (243) -- -- (243)
---------- ----------- ------------ ----------- ----------- ------------
Net cash used in investing activities (4,781) (2,237) (7,018) (1,036) -- (8,054)
---------- ----------- ------------ ----------- ----------- ------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on capital lease
obligations.......................... (28) (32) (60) (16) -- (76)
Net proceeds/(repayments) from issuance
of notes payable..................... -- -- -- 1,181 -- 1,181
Net repayments on senior credit facilit (17,687) -- (17,687) -- -- (17,687)
Proceeds from issuance of common
stock................................ 2,028 -- 2,028 -- -- 2,028
Intercompany financing of acquisitions. (2,159) 2,159 -- -- -- --
---------- ----------- ------------ ----------- ----------- ------------
Net cash (used in) financing activities... (17,846) 2,127 (15,719) 1,165 -- (14,554)
---------- ----------- ------------ ----------- ----------- ------------
Effect of exchange rate changes on cash... -- -- 70 70
---------- ----------- ------------ ----------- ----------- ------------
Net (decrease) increase in cash and
cash equivalents....................... $ (649) $ (510) $ (1,159) $ (308) $ -- (1,467)
========== =========== ============ =========== ===========
Cash and cash equivalents at beginning
of period.............................. 12,737
------------
Cash and cash equivalents at end of
period................................. $ 11,270
============
The following summarizes (in thousands) the Company's operations:
Three Months Ended March 31, ----------------------------------------- 2003 2002 ------------------ ------------------- $ % $ % -------- -------- -------- ------- Revenues............................................ $112,311 100.0 $ 97,064 100.0 Cost of revenues.................................... 61,714 54.9 55,401 57.1 Depreciation........................................ 3,453 3.1 2,774 2.9 -------- -------- -------- ------- Total cost of revenues.............................. 65,167 58.0 58,175 59.9 Gross profit........................................ 47,144 42.0 38,889 40.1 Selling, general and administrative expenses........................... 15,884 14.1 13,906 14.3 Depreciation........................................ 490 0.4 281 0.3 Amortization........................................ 321 0.3 508 0.5 Acquisition related costs........................... 91 0.1 153 0.2 -------- -------- -------- ------- Total selling, general and administrative expenses.. 16,786 14.9 14,848 15.3 Income from operations.............................. 30,358 27.0 24,041 24.8 Net income.......................................... 14,681 13.1 10,631 11.0 Other income (expense).............................. (645) (0.6) (671) (0.7) Depreciation and amortization....................... 4,264 3.8 3,563 3.7 EBITDA*............................................. 33,977 30.3 26,933 27.7 Earnings per share-diluted.......................... $ 0.32 $ 0.24
(1) Calculated for a period as the sum of net income, plus net interest expense, income tax expense, depreciation expense and amortization expense, to the extent deducted in calculating net income. We consider EBITDA to be a widely accepted financial indicator of a company's ability to service debt, fund capital expenditures and expand its business. EBITDA is not calculated in the same way by all companies and therefore may not be comparable to similarly titled measures reported by other companies. EBITDA is not a measure in accordance with accounting principles generally accepted in the United States. EBITDA should not be considered as an alternative to net income, as an indicator of operating performance or as an alternative to cash flow as a measure of liquidity. The funds depicted by the measure may not be available for management's discretionary use due to legal or functionally requirements, debt service, other commitments and uncertainties.
Revenues. Revenues increased $15.2 million, or 15.7%, to $112.3 million during the quarter ended March 31, 2003 from $97.1 million during the comparable quarter in 2002 as a result of our continued strategy of focusing on sales to higher-margin small account customers, and revenues from acquisitions completed in the quarter. International equipment related revenues were $0.7 million during the quarter as compared to $2.7 million during the comparable quarter in 2002. During the quarter ended March 31, 2003, acquisitions less than one year old contributed approximately $11.0 million to the increase in revenues as compared to the prior year. For the quarter, our base internal revenue growth for small account customers increased over 11% while revenues from large account customers increased by approximately 4%.
Cost of revenues. Cost of revenues increased $7.0 million to $65.2 million during the quarter ended March 31, 2003 from $58.2 million during the comparable quarter in 2002. The increase was primarily due to volume growth, acquisitions and higher insurance and employee benefit costs. Our gross margin percentage increased to 42.0% during the quarter from 40.1% during the same quarter in 2002 as benefits from better margins on our large customer business, the continued success of the Steri-SafeSM OSHA compliance program rollout, and lower variable costs offset higher fuel, benefit and insurance costs.
Selling, general and administrative expenses. Selling, general and administrative expenses increased to $16.7 million for the quarter ended March 31, 2003 from $14.7 million for the comparable quarter in 2002. The increase was the result of higher insurance and benefit costs and spending on the Steri-SafeSMOSHA compliance program and other strategic marketing investments. Selling, general and administrative expenses as a percent of revenues decreased to 14.9% during the quarter from 15.1% during the comparable quarter in 2002.
Income from operations. Income from operations increased to $30.4 million for the quarter ended March 31, 2003 from $24.0 million for the comparable quarter in 2002. The increase was due to higher gross profit margins, partially offset by higher selling, general and administrative expenses during the quarter. Income from operations as a percentage of revenue increased to 27.0% during the quarter from 24.8% during the same quarter in 2002 as a result of better margins and productivity improvements.
EBITDA. EBITDA increased by 26.2% to $34.0 million or 30.3% of revenue for the quarter ended March 31, 2003, as compared to $26.9 million or 27.7% of revenue for the comparable quarter in 2002. The increase in EBITDA was primarily due to the factors described above.
Net interest expense. Net interest expense decreased to $3.9 million during the quarter ended March 31, 2003 from $5.8 million during the comparable quarter in 2002 primarily due to reduced debt and lower interest rates.
Debt extinguishments. During the quarter, we incurred a total of $1.6 million in expense related to the repurchase of $9.1 million of our 12 3/8% senior subordinated notes. This amount consisted of a $1.4 million premium to repurchase the notes and a $0.2 million non-cash write- off of associated deferred financing fees.
Income tax expense. Income tax expense increased to $9.7 million for the quarter ended March 31, 2003 from $7.1 million for the comparable quarter in 2002. The increase was due to higher taxable income. The tax rate for the quarter ended March 31, 2003 decreased to 39.7% from 40.00% in the comparable quarter in 2002 as we recognized benefits from our tax planning strategies.
Net income. Net Income increased to $14.7 million for the quarter ended March 31, 2003 from $10.6 million for the comparable quarter in 2002. The increase was due to higher income from operations and lower interest expense partially offset by higher income tax expense.
LIQUIDITY AND CAPITAL RESOURCES
At March 31, 2003, our working capital was $21.8 million compared to working capital of $40.6 million at December 31, 2002. The decrease in working capital was primarily due to higher current debt balances partially offset by higher accounts receivable balances. In January 2003 we amended our senior secured credit facility to increase our borrowing capacity by $51.0 million by reclassifying borrowings under our revolving credit facility to Term A loans. At March 31, 2003 the credit facility consisted of a $105.0 million revolving credit facility, a $107.6 million Term A loan facility and a $47.0 million Term B loan facility. At March 31, 2003 we had $8.0 million outstanding under our revolving credit facility.
Under the credit agreement as amended in January 2003, we extended the maturity of the revolving credit component and the Term A loan component to September 2007 and extended the maturity of the Term B component to September 2008. Both term loans are repayable in quarterly installments on the last business day of March, June, September, and December beginning in 2003. The required principal repayments under the Term A loan component are $5.0 million on each quarterly payment date through June 2007, with a final payment of the outstanding principal balance upon maturity in September 2007. The required principal payments under the Term B Loan component are $0.2 million on each quarterly payment date through June 2008, with a final payment of the outstanding balance upon maturity in September 2008.
Net cash provided by operating activities was $28.3 million during the quarter ended March 31, 2003 compared to $21.1 million for the comparable quarter in 2002. This increase primarily reflects higher net income and and other changes in working capital.
Net cash used in investing activities for the quarter ended March 31, 2003 was $35.6 million compared to $8.1 million for the comparable quarter in 2002. This increase is primarily attributable to the Scherer acquisition. Capital expenditures were $3.8 million for the quarter, or 3.4% of revenues, compared to $3.9 million for the same quarter in 2002. This rate of capital spending is less than the 4% of revenues that we anticipate spending during 2003. Consistent with our long-term strategy, we continually evaluate our treatment technology mix. Our preference is to reduce the incineration portion, as customers' preferences, practices and regulations will allow. At March 31, 2003 we had approximately 13% of our treatment capacity in incineration and approximately 87% in non-incineration technologies such as our proprietary ETD technology and autoclaving. Cash investments in acquisitions and international joint ventures for the quarter ended March 31, 2003 were $31.3 million versus $4.0 million in the comparable quarter in 2002.
Net cash provided in financing activities was $8.2 million during the quarter ended March 31, 2003 compared to net cash used in financing activities of $14.6 million for the comparable quarter in 2002. During the first quarter we had net borrowings of $15.8 million on our senior credit facility which were primarily to fund the Scherer acquisition. In addition we paid $10.1 million in debt and capital leases which consisted of approximately $1.0 million in scheduled repayments and $9.1 million in prepayments.
We are subject to market risks arising from changes in interest rates on our senior secured credit facility. Our interest rate exposure results from changes in LIBOR or the base rate which are used to determine the applicable interest rates under our term loans and revolving credit facility. Our potential loss over one year that would result from a hypothetical, instantaneous and unfavorable change of 100 basis points in the interest rate on all of our variable rate obligations would be approximately $1.6 million. Fluctuations in interest rates will not affect the interest payable on our senior subordinated notes, which is fixed.
ITEM 4-CONTROLS AND PROCEDURES
We maintain a system of disclosure controls and procedures designed to ensure the reliability of our consolidated financial statements and other disclosures. Within the 90-day period prior to the date of filing this report, our President and Chief Executive Officer and our Chief Financial Officer carried out, with the participation of other members of management, an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon this evaluation, our President and Chief Executive Officer and our Chief Financial Officer concluded that, as of the date of the evaluation, our disclosure controls and procedures were effective in all material respects in alerting them in a timely manner to the material information about us and our subsidiaries that we are required to include in the periodic reports that we file with the Securities and Exchange Commission.
There have been no significant changes in our internal controls, or in other factors that could significantly affect our internal controls, subsequent to the date of this evaluation.
FROM TIME TO TIME WE ISSUE FORWARD-LOOKING STATEMENTS RELATING TO SUCH THINGS AS ANTICIPATED FINANCIAL PERFORMANCE, BUSINESS PROSPECTS, ACQUISITION ACTIVITIES AND SIMILAR MATTERS.
A VARIETY OF FACTORS COULD CAUSE OUR ACTUAL RESULTS AND EXPERIENCE TO DIFFER MATERIALLY FROM THE ANTICIPATED RESULTS OR OTHER EXPECTATIONS EXPRESSED IN OUR FORWARD-LOOKING STATEMENTS. THE RISKS AND UNCERTAINTIES THAT MAY AFFECT OUR BUSINESS, FINANCIAL CONDITION AND RESULTS OF OPERATION INCLUDE DIFFICULTIES AND DELAYS IN COMPLETING AND INTEGRATING BUSINESS ACQUISITIONS; DELAYS AND DIVERSION OF ATTENTION RELATING TO PERMITTING AND OTHER REGULATORY COMPLIANCE; DIFFICULTIES AND DELAYS RELATING TO MARKETING AND SALES ACTIVITIES; AND GENERAL UNCERTAINTIES ACCOMPANYING THE EXPANSION INTO NEW GEOGRAPHIC SERVICE AREAS.
PART II -- OTHER INFORMATION
See Note 10-Legal Proceedings in the Notes to the Condensed Consolidated Financial Statements. (Item 1 of Part 1).
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
99.1 Certification of Mark C. Miller, President and Chief Executive Officer
99.2 Certification of Frank J.M. ten Brink, Executive Vice President and Chief Financial Officer
During the quarter ended March 31, 2003 there were no reports filed on Form 8-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: May 6, 2003
|
STERICYCLE, INC. |
|
|
(Registrant) |
|
|
By: |
/s/ FRANK J.M. TEN BRINK |
|
Frank J.M. ten Brink |
|
|
Executive Vice President, and Chief Financial Officer (Principal Financial and Accounting Officer) |
I, Mark C. Miller, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Stericycle, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and
c) Presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function);
a) All significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and
6. The registrant's other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Date: May 6, 2003.
/s/ Mark C. Miller
Mark C. Miller
President and Chief Executive Officer
Stericycle, Inc.
CERTIFICATION
I, Frank J.M. ten Brink, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Stericycle, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and
c) Presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function);
a) All significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and
6. The registrant's other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Date: May 6, 2003.
/s/ Frank J.M. ten Brink
Frank J.M. ten Brink
Executive Vice President
and Chief Financial Officer
Stericycle, Inc.
Exhibit 99.1
Certification Pursuant to
18 U.S.C. Section 1350
(as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002)
In reference to the quarterly report on Form 10-Q for the quarter ending March 31, 2003 (the "Report"), as filed today by Stericycle, Inc. (the "Company") with the U.S. Securities and Exchange Commission, I, Mark C. Miller, the Company's President and Chief Executive Officer, certify as follows, pursuant to 18 U.S.C. 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002):
(a)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(b)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Mark C. Miller
Mark C. Miller
President and Chief Executive Officer
Stericycle, Inc.
May 6, 2003
Exhibit 99.2
Certification Pursuant to
18 U.S.C. Section 1350
(as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002)
In reference to the quarterly report on Form 10-Q for the quarter ending March 31, 2003 (the "Report"), as filed today by Stericycle, Inc. (the "Company") with the U.S. Securities and Exchange Commission, I, Frank J.M. ten Brink, an Executive Vice President of the Company and the Company's Chief Financial Officer, certify as follows, pursuant to 18 U.S.C. 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002):
(a)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(b)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ FRANK J.M. TEN BRINK
Frank J.M. ten Brink
Executive Vice President
and Chief Financial Officer
Stericycle, Inc.
May 6, 2003
7-T96US+"!);F,N``!865H@````````M5H``+QG``"2,&UF=#(`````!`,)
M```!`````````````````````0````````````````````$```$```(```(D
M!!T%V@=I"-D*-@N%#,<-_P\Q$%X1BQ*W$^(5"Q8R%U<8>1F8&K4;TASO'B4?
M62"'(;(BVB/_)2,F1"=F*(8IIRK'*^@M""XH+T@P:3&),J8SPC3>-?LW@U
M.5$Z;3N)/*4]PC[>/_A!$4(I0T)$7$5U1H]'J4C#2=U*]TP232Q.0T]94&]1
MAE*<4[)4R57?5O98#5DC6CI;45QF77A>BE^;8*UAOF+/8^!D\68"9Q)H(VDS
M:D)K4FQ>;6=N<6]Z<(-QC'*4 W"24*UV8V%@5"QW/%$T5UQX#3^46;MXU"QQ6;IY>Q35
M7^=YK```@`!^\XJQ14A^&WV$2;A^36]Z3<1^ **`)P``@`"`````@`"``%$E:C^&\D=O
M;`&&Z3S<;4&&>#$Y; F9-]K(PL@.]^!XHB:$Y^=8@33\%_
M#(8`-T%_Z(.L^.-\+J&WX4%\,YV_R3-\39GPL,)\A997F$5\WY,:?\M]3X_S
M9U9]T8RU3N]^?(E--H=_9X5<]S=[8ZT#WZ5[9J?KQZI[AZ,*KV![R9YIEOA\
M*YGX?K)\KY6W9FY]0Y%!3BY]_8Q[->5^](;O];QZRKA5WB]ZQ[(4QD-ZY*P4
MKAE[+*9AE=Q[F:#:?:1\))M9995\R)6H38)]D8^!-5M^D8A?]'=Z4L.JW.QZ
M1KPRQ0EZ7;4*K/EZIZX[E.E['Z>;?-E[MJ#H9-A\8)G=3.U]-9)0-.A^/8FG
M\V-Y]\\!V]AYX\9`P_IY\KWDJ_=Z.K7LE`)ZN*XD?"![6Z9`9$A\$)WE3&]\
MZI3C-(E]]XK%\G5YM-I:VNMYE]`RPP]YG\:4JQAYX[UJDSMZ9+1J>W=[#:M`
M8\)[S*&63`E\KYE&![)GD5DD5[>&)ID&5[^4IRCMI\DR]CCC5]?@I^D!]_
MP,LZFN*$_;=FF".#YZ,!E9F"_(WZDTV"2W@KD4.!V&%\CW6!FDE^C?>!@2YY
MC5>!XPG/CIN#",G3F=^.K;8DSB^YJK"@11RSJ#&39P;(I4:$E@``@QR``.8?=G!S&-`;
M=TMS\;F`>!]TS*(J>.IUKXHD>;)VH7%C>G]WHU>&>T]XGSLO?#%YEA:=?2%Y
MZ.0/=(=^:,YK=8E^&[?Z=GQ]Y:#+=V5]RHC=>$M]S7`N>3-]Y%9;>A5]^3H'
M>N]^$A4@>U1]P>(Q
=\UK6@``@`!R'9GA;8=BC8NC;NYE#WPQ<$%G:6NC<8QIH5GE
M
"/VT(3
27"YGTVN:7MIIOE[D841KEU$[8W)M6$(7
M94MNZS%M9F5P11Y89=YQ`0<.=!-QS@``@`"``'8C6(=P>&I>6V]QO5VU7@ER
M[5`"8%1T`4$M8D%U`#":8SMUUAVX8OMV/0;G=%5WA```@`"``'3S55-Y(6E"
M6&EYQURP6RMZ3D\1799ZO$!47XE[(C`'8%A[@QU/8(E[NP;6=')\Z@``@`"`
M`'/]4I&!N6A@5<^!QEOA6+&!IDY06S*!O4Z.)N5LV5IZ(^$VS62J()S\'6Q:'AB[>6WR'
M01R=7.2'Q0;3='B$G0``@`"``'*S3G"2FF0_&7^G_6-2R21(!5)[R,&8$